Back
PT Bank Central Asia Tbk Vs. Edwards Lifesciences Industry Stock Comparison
Buy
57
PBCRF
PT Bank Central Asia Tbk
Last Price:
0.66
Seasonality Move:
10.44%
Sell
23
EW
Edwards Lifesciences
Last Price:
67.54
Seasonality Move:
7.19%
Buy
57
PT Bank Central Asia Tbk (PBCRF)
is a Buy
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
- The current PT Bank Central Asia Tbk [PBCRF] share price is $0.66. The Score for PBCRF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PBCRF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Edwards Lifesciences (EW)
is a Sell
Is Edwards Lifesciences a Buy, Sell or Hold?
- The current Edwards Lifesciences [EW] share price is $67.54. The Score for EW is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- EW is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBCRF is experiencing slight buying pressure.
EW Stock Price Chart
What is Edwards Lifesciences's stock price today?
-
The Edwards Lifesciences share price today is $67.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EW is experiencing slight selling pressure.
PBCRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.49 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.65 - 0.71) | Sell |
| Bollinger Bands (100): | (0.59 - 0.69) | Buy |
EW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 46.25 | Sell |
| Chaikin Money Flow: | -367808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.17 - 69.75) | Sell |
| Bollinger Bands (100): | (63.09 - 84.51) | Sell |
PBCRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.66 | Sell |
| 20-day SMA: | 0.68 | Sell |
| 50-day SMA: | 0.68 | Sell |
| 200-day SMA: | 0.62 | Buy |
| 8-day EMA: | 0.66 | Sell |
| 20-day EMA: | 0.67 | Sell |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 0.63 | Buy |
EW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.93 | Sell |
| 20-day SMA: | 68.54 | Sell |
| 50-day SMA: | 67.99 | Sell |
| 200-day SMA: | 80.5 | Sell |
| 8-day EMA: | 68.43 | Sell |
| 20-day EMA: | 68.42 | Sell |
| 50-day EMA: | 69.15 | Sell |
| 200-day EMA: | 76.14 | Sell |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Edwards Lifesciences Earnings Growth & EW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.06 per share.
PT Bank Central Asia Tbk Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edwards Lifesciences Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||